We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+13.21%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$91.2B
AUM Growth
+$11.2B
Cap. Flow
+$2B
Cap. Flow %
2.19%
Top 10 Hldgs %
23.22%
Holding
3,971
New
387
Increased
1,763
Reduced
1,480
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 14.58%
2 Healthcare 8.49%
3 Financials 8.3%
4 Consumer Discretionary 6.61%
5 Industrials 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOT icon
376
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.9B
$38.4M 0.04%
181,012
+33,304
+23% +$6.56M
ATR icon
377
AptarGroup
ATR
$8.53B
$38.3M 0.04%
280,074
+21,867
+8% +$2.71M
LKQ icon
378
LKQ Corp
LKQ
$6.32B
$38.2M 0.04%
1,083,372
+32,413
+3% +$1.11M
FDS icon
379
Factset
FDS
$10.1B
$38.1M 0.04%
114,568
-521
-0.5% -$172K
MRSH
380
Marsh
MRSH
$91B
$37.9M 0.04%
323,651
-7,280
-2% -$827K
CSX icon
381
CSX Corp
CSX
$93B
$37.6M 0.04%
1,244,091
+34,206
+3% +$983K
FBT icon
382
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.81B
$37.5M 0.04%
223,227
-2,380
-1% -$386K
TTE icon
383
TotalEnergies
TTE
$196B
$37.5M 0.04%
894,533
+251,419
+39% +$9.7M
RDVY icon
384
First Trust Rising Dividend Achievers ETF
RDVY
$25.7B
$37.5M 0.04%
938,520
+411,931
+78% +$15M
MCK icon
385
McKesson
MCK
$105B
$37.4M 0.04%
215,290
-26,886
-11% -$4.48M
IHI icon
386
iShares US Medical Devices ETF
IHI
$3.46B
$37.4M 0.04%
684,672
+52,110
+8% +$2.72M
BP icon
387
BP
BP
$111B
$37.3M 0.04%
1,818,020
+113,007
+7% +$2.13M
SPLV icon
388
Invesco S&P 500 Low Volatility ETF
SPLV
$7.16B
$37.1M 0.04%
659,787
+7,179
+1% +$394K
AXS icon
389
AXIS Capital
AXS
$7.39B
$37M 0.04%
734,966
+42,190
+6% +$2.05M
AIG icon
390
American International
AIG
$40.3B
$36.9M 0.04%
974,998
-56,496
-5% -$1.99M
NDSN icon
391
Nordson
NDSN
$17.4B
$36.7M 0.04%
182,702
-9,899
-5% -$1.99M
BIL icon
392
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
$36.7M 0.04%
401,130
-56,740
-12% -$5.19M
CTXS
393
DELISTED
Citrix Systems Inc
CTXS
$36.7M 0.04%
281,991
-30,539
-10% -$3.88M
MGK icon
394
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.8B
$36.6M 0.04%
898,210
-1,590
-0.2% -$61.6K
GWW icon
395
W.W. Grainger
GWW
$61.6B
$36.5M 0.04%
89,428
+1,559
+2% +$613K
BN icon
396
Brookfield
BN
$111B
$36.4M 0.04%
1,648,635
-77,120
-4% -$1.54M
SNY icon
397
Sanofi
SNY
$105B
$36.1M 0.04%
742,745
-222,152
-23% -$11M
ALXN
398
DELISTED
Alexion Pharmaceuticals
ALXN
$35.8M 0.04%
229,183
-25,797
-10% -$3.31M
WBA
399
DELISTED
Walgreens Boots Alliance
WBA
$35.7M 0.04%
895,892
+16,381
+2% +$634K
TDG icon
400
TransDigm Group
TDG
$68.4B
$35.7M 0.04%
57,715
+1,962
+4% +$1.08M

Similar funds

Raymond James & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Raymond James & Associates held 3,971 positions worth $91.2B, up 14% from $80B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2020 filing shows 387 new, 1,763 increased, 1,480 reduced and 217 closed positions. Its largest new stake was Bentley Systems: 330,402 shares worth $13.4M. The largest sale was United Parcel Service, an estimated $69.6M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2020 buy was Bentley Systems: 330,402 shares worth $13.4M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $158M increase.
  • Raymond James & Associates's biggest Q4 2020 reduction was United Parcel Service, cutting an estimated $69.6M.
  • Raymond James & Associates fully exited GCI Liberty, Inc. Class A Common Stock (DE) in Q4 2020, selling an estimated $54.2M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $91.2B portfolio in Q4 2020.
  • Raymond James & Associates opened 387 new positions and closed 217 in Q4 2020.
  • Raymond James & Associates's portfolio value rose 14% quarter-over-quarter to $91.2B.

Based on Raymond James & Associates's 13F filing for Q4 2020, filed 12 Feb 2021.